Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

Updated September 30th, 2019

Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

NOW
PLAYING
Baby Aspirin For Colorectal Cancer Is Fine, Just Check With Doctor
NOW
PLAYING
Student, 7, Has Softball-Size Tumor Removed From Face In Cancer Battle
NOW
PLAYING
Harry Styles Helps Cancer Survivor Celebrate After Beating Disease
NOW
PLAYING
Trey Mancini Details Cancer Scare Prior To His Historic Homerun Derby
NOW
PLAYING
Katie Couric: I Never Talked Death With Husband After Cancer Diagnosis
NOW
PLAYING
Athlete's Foot Sprays Tinactin and Lotramin Recalled For Benzene

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.